FDA
approval
· 2023-02-15
FDA Tentative Approval: SAXAGLIPTIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA tentatively approves Glenmark's generic saxagliptin (SAXAGLIPTIN) under an ANDA for type 2 diabetes mellitus, subject to patent and exclusivity consideratio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG TA for SAXAGLIPTIN (SAXAGLIPTIN)